Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Musculoskeletal Disorders
Published in: BMC Musculoskeletal Disorders 1/2017

Open Access 01-12-2017 | Research article

Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL

Authors: Chi-Chien Niu, Song-Shu Lin, Li-Jen Yuan, Lih-Huei Chen, Chuen-Yung Yang, An-Ni Chung, Meng-Ling Lu, Tsung-Ting Tsai, Po-Liang Lai, Wen-Jer Chen

Published in: BMC Musculoskeletal Disorders | Issue 1/2017

Login to get access

Abstract

Background

Wnt signaling plays an important role in development and maintenance of many organs and tissues. The most-studied secreted Wnt inhibitors are sclerostin (SOST), Dickkopf-related protein 1 (DKK-1), and secreted frizzled related protein 1 (SFRP-1) which play important roles in bone turnover. The present study investigated the relationship between serum Wnt inhibitors and diseases with excessive ossification structures, such as ossification of posterior longitudinal ligament (OPLL), ankylosing spondylitis (AS), diffuse idiopathic skeletal hyperostosis (DISH), and ossification of yellow ligament (OYL).

Methods

Twenty-five patients with AS, DISH, OPLL, or OYL were recruited in this study. Fasting peripheral blood samples were collected from all patients and nine controls. Various biomarkers of bone turnover including osteocalcin (OSC), osteoprotegerin (OPG), SFRP-1, DKK-1, and SOST were investigated.

Results

Our data showed that serum levels of OSC were higher, but Dkk-1 levels were lower in AS, DISH, OPLL, and OYL patients than those in the controls. Serum levels of SFRP-1 were significantly higher in DISH patients than those in the controls. Serum levels of SOST were significantly higher in DISH and OPLL patients than both levels in the controls. Serum levels of OPG were lower in AS patients than those in the controls. Serum levels of OSC were higher in the OPLL patients than those in the AS patients. Serum levels of DKK-1, SFRP-1, SOST, and OPG were not significantly different between the different disease groups.

Conclusions

In this exploratory study, both OSC and DKK-1 levels are correlated with the clinical conditions associated with excessive ossification, indicating that blood OSC and DKK-1 levels may serve as diagnostic biomarkers for AS, DISH, OPLL, and OYL. These findings may also help discover potential drug therapies for management of these diseases in the future.
Literature
1.
2.
De Keyser F, Elewaut D, De Vos M, et al. Bowel inflammation and the spondyloarthropathies. Rheum Dis Clin North Am. 1998;24:785–813.CrossRefPubMed
3.
Gladman D. Spondyloarthropathies. In: Lahita R, Weinstein A, editors. Educational review manual in rheumatology. 2nd ed. New York: Castle Connolly Graduate Medical; 2002. p. 1–26.
4.
Devogelaer JP, Maldague B, Malghem J, et al. Appendicular and vertebral bone mass in ankylosing spondylitis. A comparison of plain radiographs with single- and dual-photon absorptiometry and with quantitative computed tomography. Arthritis Rheum. 1992;35:1062–7.CrossRefPubMed
5.
Muñoz-Ortego J, Vestergaard P, Rubio JB, et al. Ankylosing spondylitis is associated with an increased risk of vertebral and nonvertebral clinical fractures: a population-based cohort study. J Bone Miner Res. 2014;29:1770–6.CrossRefPubMed
6.
Mader R. Diffuse idiopathic skeletal hyperostosis: time for a change. J Rheumatol. 2008;35:377–9.PubMed
7.
Taguchi T. Etiology and pathogenesis. In: Yonenobu K, Nakamura K, Toyama Y, editors. OPLL; Ossification of the posterior longitudinal ligament. 2nd ed. Tokyo: Springer Japan; 2006. p. 33–5.
8.
Kawaguchi H, Akune T, Ogata N, et al. Contribution of metabolic conditions to ossification of the posterior longitudinal ligament of spine. In: Yonenobu K, Nakamura K, Toyama Y, editors. OPLL; Ossification of the posterior longitudinal ligament. 2nd ed. Tokyo: Springer Japan; 2006. p. 37–40.
9.
Nakajima M, Takahashi A, Tsuji T, et al. A genome-wide association study identifies susceptibility loci for ossification of the posterior longitudinal ligament of the spine. Nat Genet. 2014;46:1012–6.CrossRefPubMed
10.
Pascal-Mousselard H, Smadja D, Cabre P, et al. Ossification of the ligamenta flava with severe myelopathy in a black patient. A case report. Spine. 1998;23:1607–8.CrossRefPubMed
11.
Epstein NE. Ossification of the yellow ligament and spondylosis and/or ossification of the posterior longitudinal ligament of the thoracic and lumbar spine. J Spinal Disord. 1999;12:250–6.PubMed
12.
Kobayashi S, Momohara S, Ikari K, et al. A case of Castleman’s disease associated with diffuse idiopathic skeletal hyperostosis and ossification of the posterior longitudinal ligament of the spine. Mod Rheumatol. 2007;17:418–21.CrossRefPubMed
13.
Kawabori M, Hida K, Akino M, et al. Cervical myelopathy by C1 posterior tubercle impingement in a patient with DISH. Spine. 2009;34:E709–11.CrossRefPubMed
14.
Khedr EM, Rashad SM, Hamed SA, et al. Neurological complications of ankylosing spondylitis: neurophysiological assessment. Rheumatol Int. 2009;29:1031–40.CrossRefPubMed
15.
Chavez A, Maksymowych WP, Gamez-Nava JI, et al. Ossification of the posterior longitudinal ligament in three geographically and genetically different populations of ankylosing spondylitis and other spondyloarthropathies. Ann Rheum Dis. 1998;57:429–33.CrossRef
16.
Cadigan KM, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev. 1997;11:3286–305.CrossRefPubMed
17.
Westendorf JJ, Kahler RA, Schroeder TM. Wnt signaling in osteoblasts and bone diseases. Gene. 2004;341:19–39.CrossRefPubMed
18.
Rawadi G, Roman-Roman S. Wnt signaling pathway: a new target for the treatment of osteoporosis. Expert Opin Ther Targets. 2005;9:1063–77.CrossRefPubMed
19.
Schett G, Zwerina J, David JP. The role of Wnt proteins in arthritis. Nat Clin Pract Rheumatol. 2008;4:473–80.CrossRefPubMed
20.
Li X, Zhang Y, Kang H, et al. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem. 2005;280:19883–7.CrossRefPubMed
21.
Jones SE, Jomary C. Secreted frizzled-related proteins: searching for relationships and patterns. Bioessays. 2002;24:811–20.CrossRefPubMed
22.
Mao B, Wu W, Davidson G, et al. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature. 2002;417:664–7.CrossRefPubMed
23.
Daoussis D, Andonopoulos AP. The emerging role of Dickkopf-1 in bone biology: Is it the main switch controlling bone and joint remodeling? Semin Arthritis Rheum. 2011;41:170–7.CrossRefPubMed
24.
Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89:309–19.CrossRefPubMed
25.
Maeda K, Takahashi N, Kobayashi Y. Roles of Wnt signals in bone resorption during physiological and pathological states. J Mol Med. 2013;91:15–23.CrossRefPubMed
26.
Athanasios DA, Stergios AP, Avraam A, et al. The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis. Clin Endocrinol (Oxf). 2010;72:752–7.
27.
Diarra D, Stolina M, Polzer K, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med. 2007;13:156–63.CrossRefPubMed
28.
Uderhardt S, Diarra D, Katzenbeisser J, et al. Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints. Ann Rheum Dis. 2010;69:592–7.CrossRefPubMed
29.
Kwon SR, Lim MJ, Suh CH, et al. Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy. Rheumatol Int. 2012;32:2523–7.CrossRefPubMed
30.
Senolt L, Hulejova H, Krystufkova O, et al. Low circulating Dickkopf-1 and its link with severity of spinal involvement in diffuse idiopathic skeletal hyperostosis. Ann Rheum Dis. 2012;71:71–4.CrossRefPubMed
31.
Daoussis D, Liossis SNC, Solomou EE, et al. Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum. 2010;62:150–8.CrossRefPubMed
32.
Taylan A, Sari I, Akinci B, et al. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis. BMC Musculoskelet Disord. 2012;13:191.CrossRefPubMedPubMedCentral
33.
Glass II DA, Bialek P, Ahn JD, et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell. 2005;8:751–64.CrossRefPubMed
34.
Franck H, Meurer T, Hofbauer LC. Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. J Rheumatol. 2004;31:2236–41.PubMed
35.
Chen CH, Chen HA, Liao HT, et al. Soluble receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation. Clin Rheumatol. 2010;29:1155–61.CrossRefPubMed
36.
Aeberli D, Schettb G, Esera P, et al. Serum Dkk-1 levels of DISH patients are not different from healthy controls. Joint Bone Spine. 2011;78:420–32.CrossRef
37.
Kashii M, Matuso Y, Sugiura T. Circulating sclerostin and dickkopf-1 levels in ossification of the posterior longitudinal ligament of the spine. J Bone Miner Metab. 2016;34:315–24.CrossRefPubMed
38.
Resnick D, Guerra Jr J, Robinson CA, et al. Association of diffuse idiopathic skeletal hyperostosis (DISH) and calcification and ossification of the posterior longitudinal ligament. Am J Roentgenol. 1978;131:1049–53.CrossRef
39.
Bafico A, Gazit A, Pramila T, et al. Interaction of frizzled related protein (FRP) withWnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling. J Biol Chem. 1999;274:16180–7.CrossRefPubMed
40.
Sugimori K, Kawaguchi Y, Ohmori K, et al. Significance of bone formation markers in patients with ossification of the posterior longitudinal ligament of the spine. Spine. 2003;28:378–9.PubMed
41.
Ishihara C, Kushida K, Takahashi M, et al. The efficacy of biochemical markers in patients with ossification of posterior longitudinal ligament of the spine. Spinal Cord. 2000;38:211–3.CrossRefPubMed
42.
Matsui H, Yudoh K, Tsuji H. Significance of serum levels of type I procollagen peptide and intact osteocalcin and bone mineral density in patients with ossification of the posterior longitudinal ligaments. Calcif Tissue Int. 1996;59:397–400.CrossRefPubMed
43.
Chiba N, Furukawa KI, Takayama S, et al. Decreased DNA methylation in the promoter region of the WNT5A and GDNF genes may promote the osteogenicity of mesenchymal stem cells from patients with ossified spinal ligaments. J Pharmacol Sci. 2015;127:467–73.CrossRefPubMed
44.
Sohn S, Chung CK. Increased bone mineral density and decreased prevalence of osteoporosis in cervical ossification of the posterior longitudinal ligament: a case-control study. Calcif Tissue Int. 2013;92:28–34.CrossRefPubMed
45.
Yoshimura N, Nagata K, Muraki S, et al: Prevalence and progression of radiographic ossification of the posterior longitudinal ligament and associated factors in the Japanese population: a 3-year follow-up of the ROAD study. Osteoporos Int 2014;25:1089–1098.CrossRefPubMed
Metadata
Title
Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL
Authors
Chi-Chien Niu
Song-Shu Lin
Li-Jen Yuan
Lih-Huei Chen
Chuen-Yung Yang
An-Ni Chung
Meng-Ling Lu
Tsung-Ting Tsai
Po-Liang Lai
Wen-Jer Chen
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2017
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-017-1425-4

Other articles of this Issue 1/2017

BMC Musculoskeletal Disorders 1/2017 Go to the issue

Research article

Assessment of potential risk factors for new onset disabling low back pain in Japanese workers: findings from the CUPID (cultural and psychosocial influences on disability) study

Research article

The relationship between pain with walking and self-rated health 12 months following total knee arthroplasty: a longitudinal study

Research article

Plasminogen activator inhibitor-1 deficiency enhances subchondral osteopenia after induction of osteoarthritis in mice

Research article

Risk factors for first hospitalization due to meniscal lesions - a population-based cohort study with 30 years of follow-up

Research article

Measuring individual hierarchy of anxiety invoking sports related activities: development and validation of the Photographic Series of Sports Activities for Anterior Cruciate Ligament Reconstruction (PHOSA-ACLR)

Research article

The acutely injured acromioclavicular joint – which imaging modalities should be used for accurate diagnosis? A systematic review